CONTROLLED SUB. PRESCRIPTION; HOSPICE                          S.B. 127 (S-1) & 128 (S-1):

                                                                                                    SUMMARY OF BILL

                                                                                     REPORTED FROM COMMITTEE

Senate Bill 127 (Substitute S-1 as reported)

Senate Bill 128 (Substitute S-1 as reported)

Sponsor:  Senator Curtis S. Vanderwall (S.B. 127)

               Senator Curtis Hertel, Jr. (S.B. 128)

Committee:  Health Policy and Human Services

CONTENT

Senate Bill 127 (S-1) would amend Part 73 (Manufacture, Distribution, and Dispensing) of the Public Health Code to specify that a prohibition against a licensed prescriber's prescribing a controlled substance listed in Schedules 2 to 5 unless he or she is in a bona fide prescriber-patient relationship with the patient for whom the controlled substance is being prescribed would not apply to a patient who was under the care of a hospice. The bill also would specify that a requirement for a licensed prescriber to obtain and review a Michigan Automated Prescription System (MAPS) report before prescribing or dispensing more than a three-day supply of a controlled substance would not apply if the patient were the patient of a hospice and the prescriber had obtained and reviewed the MAPS report when the patient was admitted to the hospice.

In addition, the bill would delete the definition for "bona fide prescriber-patient relationship" (which would be recodified as described below).

Senate Bill 128 (S-1) would amend the Public Health Code to revise the definition of "bona fide prescriber-patient relationship". Under the bill, the term would mean a treatment or counseling relationship between a prescriber and a patient in which the following were present:

-- The prescriber has reviewed the patient's relevant medical or clinical records and completed an assessment of the patient's medical history and current medical condition, including a relevant medical evaluation of the patient conducted in person or through telehealth.

-- The prescriber has created and maintained records of the patient's condition in accordance with medically accepted standards.

MCL 333.7303a (S.B. 127)                                        Legislative Analyst:  Tyler VanHuyse

       333.7104 (S.B. 128)

FISCAL IMPACT

The bill would have no fiscal impact on State or local government.

Date Completed:  3-18-19                                        Fiscal Analyst:  Elizabeth Raczkowski

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.